FDA Approves Fortesta (Testosterone) to Treat Hypogonadism

Endo Pharmaceutical announced yesterday that the FDA has approved their Fortesta brand of 2% testosterone gel for men suffering from hypogonadism for application to the thigh to minimize accidental transfer to spouses & children.  Hypogonadism or andropause or low T is a clinical syndrome comprised of loss of energy, loss of libido (sex drive), erectile dysfunction, increase in fat despite appropriate nutrition, loss of muscle despite appropriate exercise, depression, cognitive dysfunction, and/or osteoporosis, in a person with confirmed low testosterone levels.  So now, men can choose from transdermal testosterone (Androderm, Androgel, Fortesta & Testim), pellets, injections, and buccal patches (Striant).